Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Salirasib |
Synonyms | |
Therapy Description |
Salirasib, S-trans,trans-farnesylthiosalycilic acid, disrupts the interaction of RAS with the cell membrane, thereby preventing RAS signaling (PMID: 20528225, PMID: 29992354, PMID: 29901113). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Salirasib | KD032 | RAS Inhibitor (Pan) 10 | Salirasib, S-trans,trans-farnesylthiosalycilic acid, disrupts the interaction of RAS with the cell membrane, thereby preventing RAS signaling (PMID: 20528225, PMID: 29992354, PMID: 29901113). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|